Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.

<h4>Background</h4>Localized cutaneous leishmaniasis (LCL) is a chronic ulcerating disease. A literature review identified inconsistencies in clinical trials. The aims of this study were to reach a consensus on the most important domains to measure when assessing LCL, agree on parameters...

Full description

Saved in:
Bibliographic Details
Main Authors: Shalindra Ranasinghe, Sujai Senarathne, Vijani Somaratne, Charles J N Lacey, Surangi Jayakody, Amila Wickramasinghe, Indira Kahawita, Hiro Goto, Mitali Chatterjee, José A L Lindoso, Vivak Parkash, Surya J Chaudhuri, Renu Wickremasinghe, Nilay K Das, Paul M Kaye, Alison M Layton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-08-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0012393
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849468676872339456
author Shalindra Ranasinghe
Sujai Senarathne
Vijani Somaratne
Charles J N Lacey
Surangi Jayakody
Amila Wickramasinghe
Indira Kahawita
Hiro Goto
Mitali Chatterjee
José A L Lindoso
Vivak Parkash
Surya J Chaudhuri
Renu Wickremasinghe
Nilay K Das
Paul M Kaye
Alison M Layton
author_facet Shalindra Ranasinghe
Sujai Senarathne
Vijani Somaratne
Charles J N Lacey
Surangi Jayakody
Amila Wickramasinghe
Indira Kahawita
Hiro Goto
Mitali Chatterjee
José A L Lindoso
Vivak Parkash
Surya J Chaudhuri
Renu Wickremasinghe
Nilay K Das
Paul M Kaye
Alison M Layton
author_sort Shalindra Ranasinghe
collection DOAJ
description <h4>Background</h4>Localized cutaneous leishmaniasis (LCL) is a chronic ulcerating disease. A literature review identified inconsistencies in clinical trials. The aims of this study were to reach a consensus on the most important domains to measure when assessing LCL, agree on parameters to measure the domains, and develop a tool representing a Core Outcome Set (COS), for use in clinical assessment of LCL.<h4>Methodology & principal findings</h4>A literature review was conducted to identify any existing COS for LCL embracing agreed Outcome Domains, i.e. what to measure and any Outcome Measurement Instruments (OMIs). As no COS was available, potential outcome domains for assessment of LCL were identified through an international collaborative approach using e-consultations and virtual discussions with expert stakeholders (n = 20) from geographically different LCL endemic countries. Subsequent judgmental validation process included a face-to-face multidisciplinary stakeholders' meeting adopting the Nominal Group Technique. A final consensual agreement on outcome domains and items required to measure these domains was established. "Clinical Cure" was defined as the ideal overall "General Concept". The five Core Outcome Domains included Signs capturing clinical morphology, diameter, and induration of an index lesion with the aid of a palpability score, Treatment Efficacy assessing percentage change in size of the lesion and re-epithelialization compared to baseline, Treatment Impact which included an investigator and patient visual analogue score, and Clinical Sequelae rating pigment change, atrophic and hypertrophic/keloid scars. It was agreed that two open-ended questions should be included to capture some aspects of Health-Related Quality of Life as a means of capturing a patient-focused approach.<h4>Conclusion</h4>LeishCOM_LCL was generated to reflect a COS for LCL. This captured demographic details, agreed outcome domains and measures to assess these domains. Validation of LeishCOM_LCL will be reported in a separate paper. Development of a Patient Reported Outcome Measure will be considered in the future.
format Article
id doaj-art-99e2cc4468e64c2781188f74d29b6bff
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2024-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-99e2cc4468e64c2781188f74d29b6bff2025-08-20T03:25:46ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352024-08-01188e001239310.1371/journal.pntd.0012393Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.Shalindra RanasingheSujai SenarathneVijani SomaratneCharles J N LaceySurangi JayakodyAmila WickramasingheIndira KahawitaHiro GotoMitali ChatterjeeJosé A L LindosoVivak ParkashSurya J ChaudhuriRenu WickremasingheNilay K DasPaul M KayeAlison M Layton<h4>Background</h4>Localized cutaneous leishmaniasis (LCL) is a chronic ulcerating disease. A literature review identified inconsistencies in clinical trials. The aims of this study were to reach a consensus on the most important domains to measure when assessing LCL, agree on parameters to measure the domains, and develop a tool representing a Core Outcome Set (COS), for use in clinical assessment of LCL.<h4>Methodology & principal findings</h4>A literature review was conducted to identify any existing COS for LCL embracing agreed Outcome Domains, i.e. what to measure and any Outcome Measurement Instruments (OMIs). As no COS was available, potential outcome domains for assessment of LCL were identified through an international collaborative approach using e-consultations and virtual discussions with expert stakeholders (n = 20) from geographically different LCL endemic countries. Subsequent judgmental validation process included a face-to-face multidisciplinary stakeholders' meeting adopting the Nominal Group Technique. A final consensual agreement on outcome domains and items required to measure these domains was established. "Clinical Cure" was defined as the ideal overall "General Concept". The five Core Outcome Domains included Signs capturing clinical morphology, diameter, and induration of an index lesion with the aid of a palpability score, Treatment Efficacy assessing percentage change in size of the lesion and re-epithelialization compared to baseline, Treatment Impact which included an investigator and patient visual analogue score, and Clinical Sequelae rating pigment change, atrophic and hypertrophic/keloid scars. It was agreed that two open-ended questions should be included to capture some aspects of Health-Related Quality of Life as a means of capturing a patient-focused approach.<h4>Conclusion</h4>LeishCOM_LCL was generated to reflect a COS for LCL. This captured demographic details, agreed outcome domains and measures to assess these domains. Validation of LeishCOM_LCL will be reported in a separate paper. Development of a Patient Reported Outcome Measure will be considered in the future.https://doi.org/10.1371/journal.pntd.0012393
spellingShingle Shalindra Ranasinghe
Sujai Senarathne
Vijani Somaratne
Charles J N Lacey
Surangi Jayakody
Amila Wickramasinghe
Indira Kahawita
Hiro Goto
Mitali Chatterjee
José A L Lindoso
Vivak Parkash
Surya J Chaudhuri
Renu Wickremasinghe
Nilay K Das
Paul M Kaye
Alison M Layton
Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.
PLoS Neglected Tropical Diseases
title Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.
title_full Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.
title_fullStr Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.
title_full_unstemmed Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.
title_short Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous Leishmaniasis.
title_sort development of a core outcome measure instrument leishcom lcl for localised cutaneous leishmaniasis
url https://doi.org/10.1371/journal.pntd.0012393
work_keys_str_mv AT shalindraranasinghe developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT sujaisenarathne developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT vijanisomaratne developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT charlesjnlacey developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT surangijayakody developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT amilawickramasinghe developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT indirakahawita developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT hirogoto developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT mitalichatterjee developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT joseallindoso developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT vivakparkash developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT suryajchaudhuri developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT renuwickremasinghe developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT nilaykdas developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT paulmkaye developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis
AT alisonmlayton developmentofacoreoutcomemeasureinstrumentleishcomlclforlocalisedcutaneousleishmaniasis